WHO warns against blanket travel bans over Omicron coronavirus variant

Blanket travel bans will not prevent the international spread, and they place a heavy burden on lives and livelihoods, it said

World Health Organisation, WHO
Reuters Geneva
2 min read Last Updated : Dec 01 2021 | 2:45 AM IST
Countries should apply "an evidence-informed and risk-based approach" with any travel measures related to the Omicron variant of the coronavirus, including possible screening or quarantine of international passengers, but blanket bans do not prevent its spread, the World Health Organization (WHO) said on Tuesday.
 
The WHO, in its latest guidance to authorities and travellers, said that people over 60 years of age and those with underlying health conditions should be advised to postpone travel as they are at higher risk of disease and death.
 
This was in line with its advice regarding over 60s since December 2020, regardless of a traveller's vaccination status, and did not represent any change in guidance, a WHO spokesperson said.
 
First reported in southern Africa a week ago, the variant has brought global alarm, led to travel bans, and highlighted the disparity between massive vaccination pushes in rich nations and sparse inoculation in the developing world.
 
National authorities in countries of departure, transit and arrival may apply a multi-layered approach to mitigate risk so as to delay or reduce importation or exportation of the Omicron variant, the WHO said on Tuesday.
 
"Measures may include screening of passengers prior to travel and/or upon arrival, and use of SARS-COV-2 testing or quarantine of international travellers after thorough risk assessment," it said.
 
All measures should be commensurate with the risk, time-limited and applied with respect to travellers' rights, it said.
 
"Blanket travel bans will not prevent the international spread, and they place a heavy burden on lives and livelihoods," it said.
 
Some 56 countries were reportedly implementing travel measures aimed at potentially delaying import of Omicron as of Nov, 28, it added.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus VaccineWHO

Next Story